NP1 Antibodies

Santa Cruz Biotechnology offers a broad range of NP1 Antibodies for research focused on understanding NP1's role in various biological processes. NP1 Antibodies are validated for western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). NP1, or Neuronal Pentraxin 1, plays a critical role in synaptic function and plasticity, influencing neuronal communication and development. NP1's involvement in neurodegenerative diseases and synaptic disorders makes it a significant target for therapeutic research. Understanding NP1's function can provide insights into the mechanisms underlying various neurological conditions. Researchers worldwide utilize NP1 monoclonal antibodies to advance their studies in neuroscience and related fields. The extensive applications of NP1 monoclonal antibodies enable detailed examination of neural pathways and synaptic mechanisms. Current research with NP1 monoclonal antibodies continues to reveal new aspects of neurological development and disease progression. Santa Cruz Biotechnology monoclonal antibodies for NP1 support breakthrough discoveries in neuroscience research, contributing to the advancement of therapeutic strategies for neurological disorders.